Therapeutic potential of selective modulators of nuclear receptor action
- 1 January 1998
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 2 (4) , 501-507
- https://doi.org/10.1016/s1367-5931(98)80126-9
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997
- Distinct Domains of the RelA NF-κB Subunit Are Required for Negative Cross-talk and Direct Interaction with the Glucocorticoid ReceptorPublished by Elsevier ,1997
- Effects of retinoid X receptor-selective ligands on profileration of prostate cancer cellsThe Prostate, 1997
- What's Up and Down with Histone Deacetylation and Transcription?Cell, 1997
- Intracellular receptors use a common mechanism to interpret signaling information at response elements.Genes & Development, 1996
- A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear ReceptorsCell, 1996
- Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acidNature, 1995
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995
- Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressorNature, 1995